SpectraCure AB (publ)
SPEC
Rank in Stocks
#33077
SpectraCure AB (publ) specializes in oncology, developing innovative cancer... SpectraCure AB (publ) specializes in oncology, developing innovative cancer treatments that harness laser light and photodynamic agents. A cornerstone of their research is the IDOSE software, which powers an interstitial photodynamic therapy (PDT) system. This cutting-edge system is currently in Phase II clinical trials, where its efficacy in addressing solid tumors is being evaluated. The Swedish company, established in Lund in 2003, continues to advance its therapeutic solutions.
Share Price
$0.001561
Last synced: 2026-11-09
Market Cap
$893.21K
Change (1 day)
0.92%
Change (1 year)
-92.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SpectraCure AB (publ) (SPEC)
Category
Healthcare
EPS for SpectraCure AB (publ) (SPEC)
EPS as of June 2026 TTM: $-0.01
According to SpectraCure AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for SpectraCure AB (publ) from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -39.50% |
| 2025 | $-0.02 | -30.28% |
| 2024 | $-0.02 | 4.81% |
| 2023 | $-0.02 | -16.47% |
| 2022 | $-0.02 | -6.04% |
| 2021 | $-0.03 | 28.64% |
| 2020 | $-0.02 | 20.47% |
| 2019 | $-0.02 | 27.61% |
| 2018 | $-0.01 | -26.78% |
| 2017 | $-0.02 | -20.78% |
| 2016 | $-0.02 | 21.58% |
| 2015 | $-0.02 | -45.09% |
| 2014 | $-0.03 | -40.45% |
| 2013 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -22,414.05% |
US
|
|
| $4.09 | -33,901.65% |
IE
|
|
| $9.45 | -78,199.17% |
US
|
|
| $2.37 | -19,686.78% |
US
|
|
| $1.77 | -14,728.10% |
US
|
Questions about SpectraCure AB (publ)'s earnings per share (EPS)
What is SpectraCure AB (publ)'s earnings per share (EPS)?
SpectraCure AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was SpectraCure AB (publ)'s earnings per share (EPS) in 2025?
In 2025, SpectraCure AB (publ)'s earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has SpectraCure AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, SpectraCure AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2021 ($-0.03).
How does SpectraCure AB (publ)'s earnings per share (EPS) compare with similar companies?
SpectraCure AB (publ)'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.